2024-07-22 2024-07-22 , online online, 2,290 € zzgl. MwSt. Dr. Kun Shi-van-Wielink https://forum-institut.de/seminar/24102203-healthcare-systems-across-europe/referenten/24/24_10/24102203-healthcare-systems_shi-van-wielink-kun.jpg Healthcare Systems across Europe

Enhance your market access strategy in Europe with our specialized seminar series "Healthcare Systems across Europe" tailored for professionals in the pharmaceutical industry. This program covers the key aspects of healthcare systems in Italy, Germany, the UK, France, and Spain.

Topics
  • Structure of healthcare system in France, Italy, Spain, Germany and the UK
  • Drug reimbursement and its significance for pharmaceutical manufacturers
  • Role of primary care and hospital care
  • Key players in each country
  • Building supply chains and dealing with shortages


Who should attend
This seminar is aimed at employees in the pharmaceutical industry, in particular those involved in market access and global strategy.
Aims and objectives
This seminar aims to provide comprehensive insights into the healthcare systems of Germany, Spain, France, Italy and the United Kingdom. Participants will gain an understanding of the structure, funding, key players and reimbursement procedure in each country. The seminar will also address the challenges to the supply chain and the current approaches to reform specific to each country. Participants in the seminar will identify the major similarities and differences between these countries, enabling them to optimise their market access strategies.
Your benefit

  • An understanding of the structure and functioning of healthcare systems in five key European countries
  • Local expert insights
  • Expertise to develop effective market access strategies
  • The opportunity to connect with other healthcare professionals and industry experts

Healthcare Systems across Europe

Healthcare Systems across Europe

Structure, key players, reimbursement of drugs

Benefits
  • Local expert insights
  • Expertise to develop effective market access strategies
  • Officially certified according to ISO 9001 and ISO 21001

Webcode 24102203

Jetzt buchen

JETZT Buchen
Referenten

Dr. Kun Shi-van-Wielink

Santen Pharmaceutical, Amsterdam, The Netherlands

EMEA Associate Director HEOR/RWE, Market Access

Hanna Theis

Simon-Kucher & Partners, France

Simon-Kucher & Partners, France Senior Manager, Life Sciences Hanna brings extensive expertise in European healthcare systems and the development of pricing and market access strategies in the pharmaceutical industry, with a particular focus on France and Germany. She has actively participated in AMNOG price negotiations with the GKV-SV for pharmaceuticals and a digital health application (DiGA) in Germany . She holds a Master of Science if Economics and Business Administration from Copenhagen Business School, Denmark.

Dr. Sebastian Dütting

IQVIA Commercial GmbH & Co. OHG, Germany

Director Market Access & HTA

Frederick Alskayem

Simon-Kucher & Partners, France

Simon-Kucher & Partners, France Senior Manager, Life Sciences Frederick Alskayem has experience in pricing and market access strategies, contracting agreements and product positioning in the EU, with a special focus on the French healthcare system He holds a Bachelor of Pharmacy from the Lebanese American University and a Specialized Master in digital Transformation and Strategy from Emlyon Business School, France.

Edel Falla

IQVIA, United Kingdom

Principal (Director), EMEA RWS Health Economics Edel is a Principal based in the UK and is lead of the IQVIA EMEA HTA Evidence and Strategy Centre of Excellence. Edel has hands-on experience in European reimbursement submissions, leading cross-functional teams to optimise HTA outcomes.

Steven Ferguson

IQVIA, United Kingdom

Principal, Head of Market Access

Ines Hassayoune

Simon-Kucher & Partners, France

Simon-Kucher & Partners, France Senior Manager, Life Sciences

Dr. Penelope Gallinger

IQVIA Commercial GmbH & Co. OHG, München, Germany

Principal Market Access und HTA RWAS Real-World & Analytics Solutions
More information please click here.

Brian Smith

IQVIA, United Kingdom and Ireland

Chief Pharmacist

Alles auf einen Blick

Termin

10/10/-05/11/2024

10/10/-05/11/2024

Zeitraum

Each session runs from 9:00 am to 01:00 pm.

Each session runs from 9:00 am to 01:00 pm.
Veranstaltungsort

online

online

Downloads
Gebühr

Veranstaltung - 2,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.

Veranstaltung - 2,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.

Inhouse-Angebote
Inhouse-Angebot anfordern
Inhouse-Angebot anfordern

Jetzt buchen

Your contact

Leila Grupp
Conference Manager

+49 6221 500-695
l.grupp@forum-institut.de

Details

Enhance your market access strategy in Europe with our specialized seminar series "Healthcare Systems across Europe" tailored for professionals in the pharmaceutical industry. This program covers the key aspects of healthcare systems in Italy, Germany, the UK, France, and Spain.

Topics

  • Structure of healthcare system in France, Italy, Spain, Germany and the UK
  • Drug reimbursement and its significance for pharmaceutical manufacturers
  • Role of primary care and hospital care
  • Key players in each country
  • Building supply chains and dealing with shortages


Who should attend
This seminar is aimed at employees in the pharmaceutical industry, in particular those involved in market access and global strategy.

Aims and objectives

This seminar aims to provide comprehensive insights into the healthcare systems of Germany, Spain, France, Italy and the United Kingdom. Participants will gain an understanding of the structure, funding, key players and reimbursement procedure in each country. The seminar will also address the challenges to the supply chain and the current approaches to reform specific to each country. Participants in the seminar will identify the major similarities and differences between these countries, enabling them to optimise their market access strategies.

Your benefit

  • An understanding of the structure and functioning of healthcare systems in five key European countries
  • Local expert insights
  • Expertise to develop effective market access strategies
  • The opportunity to connect with other healthcare professionals and industry experts

Detailed programme

Each session runs from 9:00 am to 01:00 pm.

Each session includes two short breaks, each from 10:30 am - 10:45 am and 12:00 pm - 12:15 pm


Dr. Kun Shi-van-Wielink

Session 1: Spain October 10, 2024
  • Overview of the Healthcare System:
    • Structure and funding of the Spanish National Health System (SNS)
    • Organization of health insurance funds
    • Variations in regional healthcare services
    • Role of primary care and hospital care
  • Key Players:
    • Ministry of Health (Ministerio de Sanidad): Governs public health, healthcare policy, and pharmaceutical regulation
    • Spanish Medicines and Medical Devices Agency (AEMPS): Regulates drug approval and market surveillance
    • Regional Health Services: Autonomous community health departments responsible for localised healthcare delivery
    • Influence of the EU on the national health system
  • Drug reimbursement system
    • Drug prescription and reimbursement processes.
    • Impact of co-payment structures on access
  • Supply chain and dealing with supply shortages
    • National level
    • Impact of EU PoliciesStakeholder roles and responsibilities

Hanna Theis, Frederick Alskayem, Ines Hassayoune

Session 2: France October 15, 2024
  • Overview of the Healthcare System:
    • Statutory health insurance (Assurance Maladie) and private supplementary insurance
    • Hospital sector: Public vs. private hospitals
    • Generalists and specialists in the French system
  • Key Players:
    • Social Security (Sécurité Sociale): Manages health insurance and reimbursement
    • National Agency for the Safety of Medicines and Health Products (ANSM): Regulates pharmaceuticals and medical devices
    • French National Authority for Health (Haute Autorité de Santé - HAS): Ensures quality of care in the healthcare system
    • Economic Committee for Health Products (CEPS): Negotiates price for retail and T2A exclusion drugs as well as their contracting agreements
    • Agence régionale de santé (ARS): Monitors drug prescription and hospital budgets
  • Drug reimbursement system
    • Drug prescription and reimbursement process
    • Alternative access pathwaysSpecificities related to innovative drugsSpecificities related to generics and biosimilars
  • Current and upcoming healthcare system trendsSocial security deficit
    • Supply shortage in France
  • Influence of the EU on the national health system
    • Parallels to German AMNOG system
    • International price referencing and comparison of prices vs other countries

Dr. Kun Shi-van-Wielink

Session 3: Italy October 22, 2024
  • Overview of the Healthcare System:
    • Structure of the Italian National Health Service (Servizio Sanitario Nazionale - SSN)
    • Healthcare delivery at regional levels
    • The balance between public and private healthcare provision
  • Key Players
    • Italian Medicines Agency (AIFA): Regulates drug approval and pricing
    • Ministry of Health (Ministero della Salute): National healthcare policies and regulations
    • Regional Health Authorities: Implement national health policies and manage regional healthcare services
    • Influence of the EU on the national health system
  • Drug reimbursement system
    • Reimbursement categories and the role of AIFA
    • Challenges and opportunities in accessing new medications
  • Supply chain and dealing with supply shortages
    • National level
    • Impact of EU PoliciesStakeholder roles and responsibilities

Edel Falla, Steven Ferguson, Brian Smith

Session 4: United Kingdom October 29, 2024
  • Overview of the Healthcare System:
    • The structure and funding of the National Health Service (NHS)
    • The role of private healthcare
  • Key Players
    • National Institute for Health and Care Excellence (NICE): Provides guidance and advice to improve health and social care
    • NHS England: Oversees the budget, planning, delivery, and day-to-day operation of the commissioning side of the NHS in England
    • Medicines and Healthcare products Regulatory Agency (MHRA): Regulates medicines, medical devices, and blood components
  • Drug reimbursement system
    • Use in primary or secondary care

Dr. Penelope Gallinger, Dr. Sebastian Dütting

Session 5: Germany November 5, 2024
  • Overview of the Healthcare System:
    • Structure of the healthcare system: Distinguishing between state and private health insurance, and organisation of health insurance funds
    • Financing of the healthcare system: Contribution-based system, principle of solidarity and redistribution mechanisms
    • Roles and functions of health authorities and institutions at federal and state level
    • Current challenges and approaches to reform: Drug shortages, innovation and sustainability in the pharmaceutical market
  • Key PlayersPhysicians and medical professionals and their role in the care process
    • Hospitals and pharmacies: Structure, functions, and challenges in care provision
    • Pharmaceutical industry and wholesalers: Their role in drug supply and interaction with other healthcare system stakeholders
    • Patient organizations and self-help groups: Their significance for the healthcare system and patient participation.
    • Influence of the EU on the national health system
  • Drug reimbursement system
    • Benefit assessment
    • Price negotiations
    • Reimbursement decisions by the Federal Joint Committee (G-BA) and the Institute for Quality and Efficiency in Health Care (IQWiG)
  • Supply chain and dealing with supply shortages
    • National level
    • Impact of EU PoliciesStakeholder roles and responsibilities

Ihr Nutzen

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

This distinguishes our events

of 5 stars of all ratings from 2023

of 5 stars on Trustpilot = good

Recommendations

Risikomanagement von Medizinprodukten

Das Seminar vermittelt grundlegendes Wissen über die Anwendung des Risikomanagements auf Medizinprodukte: Neben den Anfo...

24.10.2024, Online
Details
Masterclass China: Medical Device Marketing Authorisation for Advanced

Interested in establishing a strong presence in the Chinese medical devices market? Join our training to gain valuable i...

10. - 11.09.2024, Online
Details

Internationale Medizinprodukte-Zulassung

Der Online-Kurs gibt Ihnen einen Überblick über die Zulassung von Medizinprodukten in wichtigen Weltmärkten: Regulatoris...

30. - 31.10.2024, Online
Details

Verträge mit Krankenkassen 2024

Welche Verhandlungsoptionen und Vertragsmodelle bestehen in der GKV - das Seminar gibt Ihnen Anregungen für Ihr Produkt!

10. - 11.10.2024, Online
Details

Qualitätsmanagement für Medizinprodukte

Das Seminar vermittelt grundlegendes Wissen über Qualitätsmanagement für Medizinprodukte für Neu-und Quereinsteiger.

26.09.2024, Online
Details

Go forward

Our international course portfolio

Are you interested in our international continuous education programme? We provide a variety of specialised courses.

Details
Our international course portfolio
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality
Our rating in 2023

More than 4,500 customers have rated our training courses. Thank you for awarding us 4.3 stars out of 5.

Details
Our rating in 2023